Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05443607 · ClinicalTrials.gov registry record
Transplacental Transmission of RSV (TTRSV)
A clinical trial of Asthma and SARS CoV 2 Infection, sponsored by Tulane University.
- Active
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT05443607 is a study of Asthma and SARS CoV 2 Infection that is active but no longer recruiting, run by Tulane University. The registered enrollment target is 300 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05443607, a study of Asthma and SARS CoV 2 Infection, is active but no longer recruiting, sponsored by Tulane University.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Aim 1: To study transplacental transmission of Respiratory Syncytial Virus (RSV) and how this is moderated by other maternal infections during pregnancy Aim 2: To test maternal blood for presence of RSV-specific immunoglobulins and how this is moderated by other maternal infections during pregnancy Aim 3: To test cord blood (fetal blood) for presence of RSV-specific immunoglobulins and other common viral pathogens Aim 4: To perform further tests (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Droplet Digital Polymerase Chain Reaction (ddPCR) and immunoprobing) to confirm the presence of RSV and other common viral pathogens Aim 5: To follow these newborn infants up to 4 years of age to look for redisposition to respiratory diseases and growth parameters
Conditions Studied
Study Locations (2)
Louisiana
- Tulane University Lakeside Hospital - Metairie
- Ochsner Baptist Hospital - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-05-25 |
| Est. Completion | 2028-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05443607
The ClinicalTrials.gov registry entry for NCT05443607 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT05443607 reports 2 study locations spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT05443607 about?
NCT05443607 is a clinical study titled "Transplacental Transmission of RSV (TTRSV)". Aim 1: To study transplacental transmission of Respiratory Syncytial Virus (RSV) and how this is moderated by other maternal infections during pregnancy Aim 2: To test maternal blood for presence of RSV-specific immunoglobulins and how this is moderated by other maternal infections during pregnancy...
What is the current status of trial NCT05443607?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2020-05-25. Estimated completion is 2028-08.
What conditions does trial NCT05443607 study?
This clinical trial studies the following conditions: Asthma, SARS CoV 2 Infection, Bronchiolitis, Respiratory Syncytial Virus (RSV).
Who is sponsoring clinical trial NCT05443607?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05443607 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.